Retatrutide Starter Kit (10mg vial)
Everything for a first retatrutide vial: 10mg vial, 30 mL bacteriostatic water, syringes and swabs.

Research Retatrutide vial, dispatched from Australian stock. In Stock
| Product | Price | Per mg | Stock |
|---|---|---|---|
| Retatrutide (10mg) | $144.99 | $14.50/mg | In Stock |
| Retatrutide (15mg) | $179.99 | $12.00/mg | In Stock |
| Retatrutide (20mg) | $229.99 | $11.50/mg | In Stock |
| Retatrutide (30mg) | $329.99 | $11.00/mg | In Stock |
| Retatrutide (60mg) | $549.99 | $9.17/mg | In Stock |
Retatrutide is a single synthetic peptide that activates three receptors at once: GLP-1, GIP and glucagon. That combination is what separates it from the earlier incretin compounds, which act on one receptor (semaglutide) or two (tirzepatide). It was developed by Eli Lilly and is still in Phase 3 clinical trials, so the only form that exists is research material like this vial.
The 10mg vial is the entry format for Retatrutide: enough for assay development and first-run comparisons without committing to a larger quantity. Larger vials cost less per milligram ($9.17/mg at 60mg versus $14.50/mg here).
The full research summary, mechanism and legal status are on the Retatrutide page.
Also known as: Reta, LY3437943, R3ta, Reda peptide, retacore, reta core
Certificate of analysis. Every batch carries a certificate from an independent laboratory. Request the certificate for your batch with your order number and we send it.
For in-vitro research and laboratory use only. Not for human or veterinary use. By purchasing you confirm you are a qualified researcher and will use this compound in accordance with all applicable laws.
Add about 1 mL of bacteriostatic water slowly down the inside of the vial and swirl gently; do not shake. 10mg in 1 mL gives 10 mg/mL. Refrigerate at 2–8 °C after reconstitution and use within 8–12 weeks. The calculator has this vial preset.
Lyophilised: −20 °C, sealed, away from light and moisture. Reconstituted: 2–8 °C, used within 8–12 weeks, never frozen.
Retatrutide is an investigational drug with no marketing approval in any country, including Australia. It cannot be prescribed, dispensed or compounded for human use here. Peptide Aus supplies research-grade retatrutide for in-vitro laboratory study only; the buyer is responsible for lawful use.
Directly from Peptide Aus, from Australian stock, in 5 vial sizes from $144.99 (10mg) to $549.99 (60mg). Prices are AUD and GST inclusive. Paid orders before 2pm AEST/AEDT dispatch the same business day, tracked.
Everything for a first retatrutide vial: 10mg vial, 30 mL bacteriostatic water, syringes and swabs.
The 20mg retatrutide vial with bacteriostatic water, twenty syringes and swabs.
15mg premixed retatrutide pen with twenty pen needles and swabs. Nothing to mix.
70mg dual-chamber retatrutide pen with twenty pen needles and swabs. Water is built into the pen.
Three 20mg retatrutide vials (60mg) with bacteriostatic water, sixty syringes and swabs.
Two 30mg retatrutide vials (60mg) with bacteriostatic water, forty syringes and swabs.